About in-EV
Our company is fully dedicated to providing researchers with innovative, cutting-edge tools for research on extracellular vesicles (EVs).
Story and mission
in-EV is a subsidiary of Ciloa, a pioneer in extracellular vesicles R&D with over 15 years’ experience in the bioengineering of extracellular vesicles to develop a new generation of vaccines and therapeutic vectors.
Over the years, Ciloa has developed advanced tools, technologies and know-how in the domains of EV bioengineering, EV production, EV purification and EV characterisation, overcoming major technological bottlenecks and building a robust pipeline of bioengineered EVs.
With increasing interest from the EV scientific community, it became clear that these tools could benefit a much broader range of laboratories. The creation of in-EV marked the transition from internal innovation to shared access, making Ciloa’s cutting-edge EV technologies available to academic and industrial researchers worldwide.
Our mission is to enable the broader scientific community to benefit from the tools and technologies developed by Ciloa, in order to accelerate progress in extracellular vesicle research.
We are committed to ensuring that our products themselves are of the highest quality, becoming references for their performance.
Through the close collaboration with Ciloa, in-EV continuously creates, adapts and improves its products to support robust, reproducible and high-quality EV research, contributing to the advancement of the field as a whole.
Partnerships
We have built strong relationships with academic and industry partners to combine our expertises and advance life science research. Through these collaborations, we generate valuable experimental data and develop application notes that highlight the capabilities and potential uses of in-EV technologies.
